电视辅助胸腔镜与开胸支气管袖状肺叶切除术治疗中央型非小细胞肺癌的比较
本研究纳入2013年1月至2017年12月接受支气管袖状肺叶切除术的非小细胞肺癌患者363例,其中开胸组251例、电视辅助胸腔镜手术(VATS)组112例。经倾向性评分匹配后,VATS组术中出血量、术后住院时间、胸管引流时间及重症监护室停留时间均少于开胸组,而手术时间、并发症率及30至90天死亡率相当;两组3年总生存率和无复发生存率相似。结论认为在适当选择患者并积累经验的前提下,VATS袖状肺叶切除术短期围手术期安全,且不影响肿瘤学结局。
要点
- 匹配后VATS组术中出血量、术后住院时间、胸管引流时间及ICU停留时间均少于开胸组。
- 两组手术时间、并发症率及30至90天死亡率相当。
- 两组3年总生存率和无复发生存率相似(log-rank P=.24和.20)。
核心结论
- 在适当选择患者并积累经验的前提下,VATS袖状肺叶切除术短期围手术期安全,且不影响肿瘤学结局。
研究设计与样本
- 回顾性纳入2013年1月至2017年12月接受支气管袖状肺叶切除术的非小细胞肺癌患者363例,开胸组251例、VATS组112例,并进行倾向性评分匹配。
- 匹配后开胸组116例与VATS组72例进行比较。
主要发现
- 匹配后VATS组术中出血量(P<.01)、术后住院时间(P<.01)、胸管引流时间(P<.01)及ICU停留时间(P=.03)均少于开胸组。
- 两组手术时间、并发症率及30至90天死亡率相当。
- 两组3年总生存率和无复发生存率相似(log-rank P=.24和.20)。
- 多因素分析显示晚期TNM分期与更差的总生存率和无复发生存率独立相关;年龄较大仅预测更差的总生存率(HR 1.04,95%CI 1.01-1.07,P=.02)。
- 体重指数也是预测因素(总生存率:HR 0.93,95%CI 0.86-0.99,P=.03;无复发生存率:HR 0.93,95%CI 0.87-0.99,P=.02)。
临床怎么用
- 对于中央型非小细胞肺癌需行支气管袖状肺叶切除术的患者,在适当选择和积累经验后,VATS可作为开胸手术的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to investigate the adequacy of bronchial sleeve lobectomy by video-assisted thoracoscopic surgery in perioperative outcomes and its oncological efficacy by comparing with thoracotomy in a balanced population. METHODS: A total of 363 patients who received bronchial sleeve lobectomy for non-small cell lung cancer from January 2013 to December 2017 were included and placed in the thoracotomy (n = 251) and video-assisted thoracoscopic surgery (n = 112) groups. Statistical analyses were performed to compare patients' demographics, perioperative outcomes, and survival between the 2 groups. RESULTS: A total of 116 thoracotomy cases were matched with 72 video-assisted thoracoscopic surgery cases by propensity score. Compared with thoracotomy, patients in the video-assisted thoracoscopic surgery group after matching had less intraoperative blood loss (P < .01) and length of postoperative hospital stay (P < .01), duration of chest tube drainage (P < .01), and intensive care unit stay (P = .03) despite comparable operative time, complication rate, and 30- to 90-day mortality rate. The overall survival and recurrence-free survival were similar in patients who received sleeve lobectomy by thoracotomy and video-assisted thoracoscopic surgery (log-rank, P = .24 and .20, respectively) at 3 years. Although advanced TNM stage was independently associated with worse overall survival and recurrence-free survival in multivariable analysis, older age was only predictive for worse overall survival (hazard ratio, 1.04; 95% confidence interval, 1.01-1.07; P = .02). Body mass index was also found be a predictive factor (overall survival: hazard ratio, 0.93; 95% confidence interval, 0.86-0.99, P = .03; recurrence-free survival: hazard ratio, 0.93; 95% confidence interval, 0.87-0.99, P = .02). CONCLUSIONS: With appropriate patient selection and continued experience, video-assisted thoracoscopic surgery appears to be safe in the short-term perioperative period and does not appear to comprise oncologic outcomes in performing sleeve lobectomy.
引用
- Xie D, Deng J, Gonzalez-Rivas D, et al. Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020. PMID: 32386762. doi:10.1016/j.jtcvs.2020.01.105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。